An effect-size analysis of pharmacologic treatments for generalized anxiety disorder

Generalized anxiety disorder (GAD) is a prevalent and impairing disorder, associated with extensive psychiatric and medical comorbidity and usually characterized by a chronic course. Different drugs have been investigated in GAD; among them are the following: 1) SSRIS: paroxetine, sertraline, fluvox...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of psychopharmacology (Oxford) 2007-11, Vol.21 (8), p.864-872
Hauptverfasser:	Hidalgo, Rosario B., Tupler, Larry A., Davidson, Jonathan R. T.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adolescents Adult Adult and adolescent clinical studies Adults Alprazolam Anti-Anxiety Agents - therapeutic use Antihistamines Anxiety Anxiety Disorders - drug therapy Anxiety disorders. Neuroses Benzodiazepines Biological and medical sciences Buspirone Care and treatment Child Children Citalopram Diazepam Double-Blind Method Drug therapy Drugs Fluvoxamine Generalized anxiety disorder Humans Lorazepam Medical sciences Meta-analysis Miscellaneous Neuropharmacology Panic attacks Paroxetine Pharmacology. Drug treatments Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Randomized Controlled Trials as Topic Serotonin uptake inhibitors Sertraline Teenagers Venlafaxine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!